Member Info for stt1

Hallsworthy,

"Now you're saying you think cash will be below 37 in the interims (in September? Another stupid error I'm guessing, you didn't mean interims you meant year end). "

Not at all, I mean what I've posted. Interims, ie H12024, which ends 30th June 2024. I think cash will be lower than £37m.

Are you predicting cash will be significantly higher than £37m or won't you say because you are incapable of forming an opinion?

It's funny how you ignore the facts and are very selective in the metrics to suit your agenda.

The Chairman dumped majority of his holding after the media tips or are you denying that was the case???.

It backs up my assertion that they were being talked up so they can sell.

It is a fact.

What's your opinion of where cash will be H12024 or are you refusing to answer because you don't want to embarrass yourself?

Ricky

"You have been on about Hvo being a pump and dump ever since the 9p days and compared it unfavourably with Tly which were 30p+."

That's not the case.

I've been raising questions about the business model since 2021. The sp at that time (Sept 2021) was around 27pp, marginally lower than the current sp and only 1p lower than not much lower than the founder's 28p at which he dumped majority of his holding.

I post the company newsflow.

I raised questions over the business model, the missed expectations.

Whatever happened to the significant value that was supposed to be in DiM and it's IPO???

It's not mentioned anymore is it?

Why's that?

https://www.lse.co.uk/profiles/stt1/?page=28

If a share is talked up then some will buy in believing what they being told rather than checking facts for themselves.

TLY is just one of the companies I comment on.

Facts are, around 40% of TLY is held by IIs and some were increasing over the past 6months. Plus the Chairman has also been buying.

Plus they have been winning contracts recently.

Mcap £10m

Those are facts.

Ricky,

Onto the points about the company.

"The Company is growing revenue's by £6m + p.a (obviously this equates to a smaller % as they get bigger)"

That's the point, the company is portrayed as if it's growing significantly but the figures say otherwise. Growth has slowed signficiantly.

"obviously this equates to a smaller % as they get bigger"

Yes, obviously.

Yet in their presentation, they quote 15% yoy!!!

"More importantly, profitability and cash generation is moving at a higher percentage"

I think cash will decline from the £37m (stated in the TU) when it comes to the interims.

"you stated on March 13th 'Despite all the talking up, no evidence of significant buying/holding by institutionS.' - which has since been shown to be completely wrong. "

Note the 'S' in institutionS was in caps, so highlighted. There was no evidence of significant buying/holding by institutions in 2021, 2022, 2023. Yet since the CEO gets awarded his huge 7m options, some IIs buy tiny amounts.

Also the CEOs options are due to be exercisable from a year's time. So just months before his options are exercisable, there's an increase in media tips, soon after the Chairman/Founder dumps majority of his holding. Some IIs start to buy in tiny amounts.

This is being talked up.

Ricky

"Stt - you seem to have a grudge against certain posters (who probably cost you after you followed their recommendations)"

On the contrary, I haven't lost anything and I never followed anyone's recommendation. I traded some shares (trmr, rthm, byot), whilst continuing to post the warnings/red flags and rational bear case and sold based on my warnings and assertions and my own opinion.

All documented, see my posts. I sold trmr at 844p, high was around 870p, now around 200p (company now called nexn).

https://www.lse.co.uk/profiles/stt1/?page=30

Are YOUR investments dependent on what I think and nobody else?

Tell us what will the cash be at 31st March 2024 or the interims?

How much higher than £37m?

Fy2023 Ebitda & margins as well?

Readers can see for my posting history for themselves.

Read pages 70 to 80. Byot was being pumped, I posted the warnings and company/sector newsflow, the rampers more interested in the sp. The shares crashed and company confirmed was saying similar to my warnings.

https://www.lse.co.uk/profiles/stt1/?page=80

Hallsworthy

Your post:

"Stt, with HVO results around the corner, what revenue and what profit level would you consider "good" with guidance at £56m, already ahead of market expectations"

Why not state what you, given you suggest to others they should ignore me? Is it because you know I've been right in the past on Byot, Trmr, rthm, etc etc...

What would you say the cash as of March 31st or interims will be? Declining or significantly ahead of the £37m?

What about for fy results:

Ebitda?

Margin?

There's a cancelled 50k trade gone through.

Look at all the small trades coming through.

The other point worth making.

The company will be paying for 2 leases for months. The current one and the new one at the new facility.

"The new facility's first phase is anticipated to reach completion in Q1 2024, with the full site expected to be operational by Q2 2024. hVIVO's current Whitechapel and Queen Mary Bioenterprises Centre (QMB) clinics will close in 2024 but will remain fully operational throughout this transition, ensuring uninterrupted service delivery to the Company's clients."

https://polaris.brighterir.com/public/hvivo/news/rns/story/xlkgv3w/export

How much is the new lease costing them?

Luckymaybe

"Please post the evidence"

Read the rns', company newsflow.

Read my posting history. Look at the warnings on Trmr/RTHM/Nano/Byot. Virtually everything came true and shares crashed.

Company newsflow:

There's no evidence of institutions buying in 2021, 2022, 2023.

Shares on loan avg around 10-11m during 2022-2023.

Feb 2022 - CEO appointed.

Feb 2023 - CEO receives >7m options, awarded to 1 director.

Talk of nominal dividend, institutions buying 1-2%, which is hardly anything for institutions.

Repeatedly tipped in media over past 3 months, same message repeated.

Shares rise on media tips.

After they were tipped in the media,

Feb 2024 Chairman dumps majority of his holding at 28p. He had been buying 2.5years earlier at around 26p and they reached profit since.

The company figures show growth has slowed significantly

Fy2022: £48.5m (+30%)

Fy2023: £56m (+15.5%)

Fy2024: £62m(+10.7%)

"Full year revenue of £56.0 million, an increase of 15.5% (2022: £48.5 million)

Revenue guidance of £62 million for 2024"

https://polaris.brighterir.com/public/hvivo/news/rns/story/xopzn1r/export

My posting history is consistent.

https://www.lse.co.uk/profiles/stt1/

I see a questionable business model

What's new in that presentation? Nothing.

It's the same stuff.

The Chairman/Founder obviously knew what was going to be said.

Yet, he still dumped majority of his holding recently. Why?

I consider that as a major red flag.

The CEO has huge > 7m options, which were awarded only a year ago and exercisable from a year's time. That's why I believe they are being talked up so much.

There's no evidence of significant buying/holding by institutions in 2021, 2022, 2023. Company being talked up and institutions take a small stake.

Look at the presentation, yourselves. They clearly show that growth (revenue/order book) has slowed significantly.

Questionable business model.

TwoGood2Die

Your post 4th March, where you claimed you were posting facts.

"Totally Plc fails consistently to deal with NHS waiting lists...FACT!

To date waiting lists have become worse due to Totally Plc....FACT!"

Waiting lists are down and not worse.

Going by your logic, fact as you claim, waiting lists have become worse due to TLY. Given waiting lists have gone down then that must be due to TLY as well. After all, it's YOUR fact, voted up 4 times.

I await your post congratulating TLY on reducing waiting lists. :-)

FACT.

Waiting lists gone down despite the junior doctors strike.

https://www.dailymail.co.uk/health/article-13196291/NHS-waiting-list-strike-action-patients-delays-AE.html

It's amazing some are completely clueless. They've been quoting the total liabilities for YEARS, despite this being explained clearly regularly.

Yet the company still managed to buy other companies, win national contracts, pay dividends.

Have you looked at the current liabities and assets at HVO, a share you're ramping?

They have total liabilities of £31m (as of fy2022, latest AR not available yet) and yet they will be paying for 2 leases for several months, as of beginning of this year.

Sanderling,

"Saw the JP Morgan Smaller Companies Investment Trust has 11m shares"

Not much more than the CEO's > 7m options, is it?

This is being talked up.

Read the company newsflow, especially the growth figures around revenues/order book.

The CEO dumped majority of his holding recently. He obviously knows the figures.

Blackrhino

"Mo dropped in that the update on the final accounts would be early April. That should give them a good opportunity to update us on the order book"

Given the final accounts were April last year, then it's obvious the final accounts will around the same time this year.

Have they announced any orders to suggest the order book will be any different to what they've already stated? No.

"The longer they wait the more they’ll have to pay ."

Best wait to see what the final results reveals then. If the figures continue to show a significant slowdown in revenue/orders rate then those waiting could end up paying less.

;-)

Blackrhino

"Very professional, controlled and reassuring."

It would be. They are being talked up. Nothing new though, was there?

The CEO has huge > 7m options, awarded a year ago, exercisable in a year.

So much promise, the Chairman/Founder dumped majority of his holding recently.

Don't take my word for it, look at the last 2 rns.

They have a questionable business model.

"The whole point of them moving to the new facility in Canary Wharf is to be able to run concurrent challenge models and hence growing revenue faster."

From fy2022 to fy2023, their order book rose just 5%, £76m to £80m. How do you suppose they will grow revenues faster?

Are you saying they have been turning down new orders?.

It's their figures from their presentation.

fy2023 to fy2024 revenues up 10%, not the 15% they mention.

fy2022 to fy2023 net contracted order book up only 5%, £76m to £80m.

Both show significant slowdown.

Kilman,

"Growth has slowed significantly."

I see a company increasing revenue/profits "

Readers. Look at page 6 of the presentation.

Revenue

2023 £56m

e2024 £62m

Use any calculator and you'll see the revenue increase from 2023 to 2024 is 10% and not the 15% yoy they mention(fy2021 to fy2022 was 15%, which was significantly lower than the previous year). That backs up my assertion that growth has slowed significantly.

Growth slow significantly

Fy2022: £48.5m (+30%)

Fy2023: £56m (+15.5%)

Fy2024: £62m(+10.7%)

Just the same 'talking up'.

As commented before, it's been talked up....

You have to wonder why, with all the talking up suggesting business is booming, the Chairman/Founder dumped the majority of his holding recently??

The facts haven't changed.

The CEO has a huge > 7m options which were awarded a year ago and exercisable in a year.

Chairman/Founder dumped majority of his holding recently.

Growth has slowed significantly.

Clients largely paying for the new facility.

Despite all the talking up, no evidence of significant buying/holding by institutionS.

I see a questionable business model, where growth has slowed significantly.

Read the company newsflow.

An increasing number of Elective Care procedures are being carried out by Private Providers.

Revealed: The ICBs most reliant on private hospitalsBy James Illman23 February 2024 Bath

Up to 20 per cent of NHS elective patients are now being treated by private hospitals in some areas, analysis by HSJ suggests.

https://www.hsj.co.uk/quality-and-performance/revealed-the-icbs-most-reliant-on-private-hospitals/7036620.article

Great to see another contract win in Republic of Ireland.

Shows those that say TLY have only 1 customer are clueless.

TLY provide their services in all 4 UK Nations and Republic of Ireland. Each UK Nation has many local NHS Bodies.

Given the NHS year end is 31st March, I would expect to see some contract wins/extensions within the UK, either during March or April.